Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab.
Anticancer research（2023）
摘要
Our study findings indicate that sPD-L1 might be a predictor of treatment response to nivolumab in patients with mRCC.
更多查看译文
关键词
PD-1,PD-L1,Renal cell carcinoma,immune checkpoint inhibitors,nivolumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要